MSF welcomes GSK's decision to lower the price of the pneumonia vaccine for some of the world's most vulnerable children.
On September 20th, 2016 Médecins Sans Frontiéres/Doctors without Borders (MSF) welcomed the decision by GlaxoSmithKline (GSK) to lower its price of its pneumococcal conjugate vaccine (PCV) for humanitarian organizations that serve refugee and crisis-affected children.
Read on for the entire announcement here.
Apr 25, 2024
Despite being preventable and treatable, malaria kills nearly half a million people and infects over 200 million worldwide every year – 70 per cent of whom are children under five years old. ... Read more
Apr 22, 2024
"ReconAfrica's oil exploration activities have damaged homes, devastated subsistence crops, and destroyed land, illegally and without the consent of local Indigenous communities. They’ve demonstrated... Read more
Apr 19, 2024
Tuesday’s federal Budget contained a modest increase to Canada’s investment in humanitarian assistance. This was welcomed by Canadian civil society organizations, and was especially good to see,... Read more